Syndrome d'hypersensibilité au célécoxib

@article{Fradet2001SyndromeDA,
  title={Syndrome d'hypersensibilit{\'e} au c{\'e}l{\'e}coxib},
  author={G{\'e}rard Fradet and Anne Robin Le N{\'e}chet and Anne Chiffoleau and S. Kazara and Thierry Charlois},
  journal={Revue de M{\'e}decine Interne},
  year={2001},
  volume={22},
  pages={170}
}
Coxib: una alternativa terapéutica factible en pacientes con intolerancia o hipersensibilidad al ácido acetilsalicílico, antiinflamatorios no esteroideos y paracetamol
TLDR
The use cyclo-oxigenase-2 specific inhibitors (COXIB) is analyzed, a therapeutic modality analyzed in the present paper, for the management of intolerance and hypersensitivity reactions with the use of NSAIDs and/or aspirin.
Prevalencia de control glucémico y factores relacionados en pacientes con diabetes mellitus tipo 2 del Hospital Universitario de San Ignacio, Bogotá, Colombia
TLDR
El abordaje integral del paciente con diabetes mellitus tipo 2 es fundamental para planear intervenciones preventivas y terapeuticas eficaces.
Safety of celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance.
TLDR
The study proves therefore Celecoxib safety on a 72-hour observation period and determines tolerance of Cele Coxib by oral challenge test in patients who showed skin reactions after taking ASA and/or NSAIDs.